Meet The Team
Steven H. Shapiro is the leader of the Corporate Group at DUGGAN BERTSCH. He is an award-winning former General Counsel, a nationally recognized speaker on corporate and technology topics and a highly accomplished transactional lawyer. Steve has completed numerous M&A transactions in a variety of industries. He also has successfully completed dozens of complex securities offerings, bank financings and venture capital fundings, representing underwriters and issuers, lenders and borrowers and funds and start-up companies.
Steve also has extensive experience in technology contracting and related transactions, such as software licenses, SaaS agreements, cloud services agreements, technology equipment sales and purchase, terms of services, privacy policies and technology consulting agreements. In performing this work, he has served as counsel to technology vendors as well as to purchasers and licensors of technology and technology consulting.
Steve graduated Columbia University cum laude and with awards for service to the academic community as well as the University of Chicago Law School. A native New Yorker, Steve has lived in the Chicago area since graduating law school.
The Illinois Super Lawyers and Rising Stars is an honor reserved for those lawyers who exhibit excellence in practice. Only 5% of attorneys in Illinois receive this distinction. Attorneys are selected through a patented selection process involving nominations, research, and peer reviews. In addition to our numerous prior and existing award recipients, DUGGAN BERTSCH, LLC […]
On January 5, 2023, the Federal Trade Commission (“FTC”) proposed a new rule that would prohibit non-compete provisions for workers and require employers to rescind existing non-competes. The proposed rule would apply to all employees, independent contractors, and consultants. The broad proposed rule would apply even to senior level executives and could potentially implicate agreements […]
“But there are legal considerations around actually using it that depend on city and state rules. According to the Prescription Drug Abuse Policy System, a database of prescription drug laws operated by Temple University’s Beasley School of Law, in 13 states, including Virginia, Arizona, and Florida, someone who administers the medication to another person does […]
Dear Clients and Colleagues, As the fourth quarter of 2022 is drawing to a close, we recommend that you review your comprehensive wealth planning and business structures to ensure that it is consistent with your long-term objectives. While the recent mid-term election results are still not final, with a Senate run-off left in Georgia, it […]
As indicated above, the recent changes to congressional control following the mid-term elections will likely mean a stalemate in Congress for the next 2 years with respect to any meaningful tax legislation. This means that from an estate planning perspective, the increased lifetime exemptions enacted as part of TCJA will continue to be available for […]
The relationship between individual taxpayers and their businesses continue to offer opportunity for effective tax savings, including the use in certain circumstances of C corporation structures to arbitrage tax rates, allow for greater deductions and potentially offer savings on an exit. However, much tax planning continues to focus on accessing these benefits before they sunset […]
The TCJA imposed a $10,000 limitation on individual’s deduction for payment of state and local taxes in itemizing their deductions. For many high taxed states, this resulted in significant limitations on state income and property tax deductibility and resulted in an effort to find a workaround from the legislation to allow for deductibility. Most states […]
The conference took place in Nashville from October 11-13, 2022. Tim spoke on the Terms & Conditions Power Panel. CLICK HERE for a recap on part 1 of the Terms & Condition Power Panel: https://www.ieba.org/2022panelrecaps/terms-amp-conditions-power-panel-part-1-insurance-and-employment-practices CLICK HERE for a recap on part 2 of the Terms & Condition Power Panel: https://www.ieba.org/2022panelrecaps/terms-amp-conditions-power-panel-part-2-contracts-and-yet-another-discussion-of-cois CLICK HERE for a […]
When a professional baseball player is accused of using performance-enhancing drugs (“PEDs,” inclusive of hormones for purposes of this article), the implications can be catastrophic.